A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Participants

NCT01866033 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: PCI-32765 (Treatment A)
DRUG: PCI-32765 (Treatment B)
DRUG: PCI-32765 (Treatment C)
DRUG: 13C6 PCI-32765 (reference)

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]